Cocrystal Pharma Inc (COCP): Earnings per share for the last twelve months

Corporate company logo of Cocrystal (COCP)

Effective management at Cocrystal Pharma, Inc. (COCP) ensures strict control over R&D expenditures and testing transparency. The rolling annual earnings per share demonstrate resilience, where -0.76 determines this parameter level. The company complies with environmental waste disposal regulations, establishing a foundation for the monetization of antiviral patents through strategic partnerships with industry behemoths.

Cocrystal Pharma, Inc. (COCP) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/15/2026

COCP (Cocrystal Pharma Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Cocrystal Pharma Inc|COCP - Analyst Median Target
- stock exchange capitalization data:
Market Value Cocrystal Pharma Corp|COCP - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share Cocrystal Pharma|COCP - Book Capitalization|Market Value to Book Value Ratio cocrystalpharma.com|COCP - Company Total Asset Base
- debt obligations and liquidity statistics:
Total Debt to Capital Cocrystal Pharma, Inc.|COCP - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Cocrystal Pharma Inc|COCP - Company Cumulative Debt|Debts to Book Capitalization Cocrystal Pharma Corp|COCP - Company Long-Term Liabilities|Company Short-Term Debt Cocrystal Pharma|Quick Liquidity Indicator cocrystalpharma.com
- earnings and valuation multiples indicators:
COCP - Company Net Income|Expected Profit Cocrystal Pharma, Inc.|COCP - Business Payback Period|Projected Price to Earnings Cocrystal Pharma|COCP - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Cocrystal Pharma Inc|COCP - Operating profit EBITDA|Earnings per share for the last twelve months Cocrystal Pharma|COCP - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months cocrystalpharma.com|COCP - Earnings per share increase in current year|Net earnings per share growth forecast for next year Cocrystal Pharma, Inc.
- sales and revenue data:
COCP - Company Annual Revenue|Projected Sales Volume Cocrystal Pharma|COCP - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Cocrystal Pharma Inc
Basic company analysis:Cocrystal Pharma Inc (COCP)
Manufactured products of Cocrystal

Asset managers require an objective assessment of the actual yield for each of the issuer's shares. This indicator calculates the total annual net income divided by the total number of shares. Analyzing the 12-month per-share net income chart allows for the identification of hidden risks regarding stagnant operational inflows. For Cocrystal Pharma, Inc. (COCP), this metric reflects the investment stage of its antiviral developments. Growth in this metric is expected following the commercialization of drugs against influenza and COVID-19.

Competitor analysis

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months SIGA Technologies Inc (SIGA)|EBS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AVIR (Atea Pharma)|Net earnings per share for the last four quarters Invivyd, Inc. (IVVD)|ENTA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Inovio|HilleVax (HLVX) - Earnings per share for the last twelve months|KLRS (Kalaris Therapeutics) - Earnings per share for the last twelve months|DYAI (Dyadic International, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NanoViricides NNVC|Net earnings per share (EPS TTM) TLPH|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters